Fig. 3From: Onabotulinumtoxin A for the management of chronic migraine in current clinical practice: results of a survey of sixty-three Italian headache centersMost important indicator of treatment efficacy (a) for clinicians and (b) for patients (as assessed by clinicians)Back to article page